Literature DB >> 19571110

Performance of the Epstein-Barr virus and herpes simplex virus immunoglobulin m assays on the liaison platform with sera from patients displaying acute parvovirus B19 infection.

Elisa Costa1, Nuria Tormo, María Angeles Clari, Dayana Bravo, Beatriz Muñoz-Cobo, David Navarro.   

Abstract

Acute parvovirus B19 infection has been reported to cause false-positive results frequently in the Epstein-Barr (EBV) and herpes simplex virus (HSV) immunoglobulin M (IgM) assays from DiaSorin performed on the Liaison platform. We tested 65 sera from patients with a presumptive or conclusive diagnosis of acute parvovirus B19 infection in both assays and obtained no false-positive results in the EBV IgM test and 10.4% nonspecific reactivities in the HSV IgM assay. Our data support the specificity of both assays in this clinical setting.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19571110      PMCID： PMC2725526          DOI： 10.1128/CVI.00142-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  8 in total

1.  Prevention of assay interference in infectious-disease serology tests done on the liaison platform.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

2.  Cross-reactions in rubella and parvovirus specific IgM tests.

Authors:  J B Kurtz; M J Anderson
Journal:  Lancet       Date:  1985-12-14       Impact factor: 79.321

3.  Dual infection with rubella and human parvovirus.

Authors:  B J Cohen; J A Shirley
Journal:  Lancet       Date:  1985-09-21       Impact factor: 79.321

4.  Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection.

Authors:  David Navalpotro; Concepción Gimeno; David Navarro
Journal:  J Med Virol       Date:  2006-11       Impact factor: 2.327

5.  Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis.

Authors:  S Doyle; S Kerr; G O'Keeffe; D O'Carroll; P Daly; C Kilty
Journal:  J Virol Methods       Date:  2000-11       Impact factor: 2.014

6.  Assessment of the specificity of a commercial human parvovirus B19 IgM assay.

Authors:  I P Jensen; B F Vestergaard
Journal:  Clin Diagn Virol       Date:  1997-02

7.  Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity.

Authors:  M Söderlund; C S Brown; B J Cohen; K Hedman
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

8.  Acute parvovirus B19 infection frequently causes false-positive results in Epstein-Barr virus- and herpes simplex virus-specific immunoglobulin M determinations done on the Liaison platform.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2008-12-30
  8 in total
  6 in total

1.  Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.

Authors:  Isabel Corrales; Estela Giménez; David Navarro
Journal:  Clin Vaccine Immunol       Date:  2014-03-12

Review 2.  Immunoglobulin M for Acute Infection: True or False?

Authors:  Marie Louise Landry
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

3.  Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

4.  Facial nerve palsy secondary to Epstein-Barr virus infection of the middle ear in pediatric population may be more common than we think.

Authors:  Katarina Vogelnik; Aleš Matos
Journal:  Wien Klin Wochenschr       Date:  2017-09-18       Impact factor: 1.704

5.  Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.

Authors:  Alvaro Guerrero-Ramos; Mauli Patel; Kinjal Kadakia; Tanzina Haque
Journal:  Clin Vaccine Immunol       Date:  2014-04-02

6.  False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity.

Authors:  Laura Vandervore; Eugénie Van Mieghem; Vicky Nowé; Sofie Schouwers; Charlotte Steger; Pascale Abrams; Jozef Van Schaeren; Anissa Meskal; Timon Vandamme
Journal:  Diagn Microbiol Infect Dis       Date:  2022-01-31       Impact factor: 2.803
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.